Healthcare decisions are inherently agonizing, and in the United States, this agony is compounded by the uncertainty of what will or will not be covered by insurance.
This accelerated and higher seroconversion rate came at no cost to safety, with the safety profile of the PIKA Rabies Vaccine remaining highly tolerable.